Equity Holdings of Nippon India Pharma Fund

Here is the most recent list of equity holdings in the Nippon India Pharma Fund's portfolio as of 31 Jan 2024 . The fund's AUM is 6,891.31 crores, of which equity holdings constitute 99.23%.

Name of the EquityHolding Percentage
SUN PHARMACEUTICAL INDUSTRIES LTD. 13.50%
LUPIN LTD. 8.31%
CIPLA LTD. 6.08%
APOLLO HOSPITALS ENTERPRISE LTD. 5.98%
DR.REDDY'S LABORATORIES LTD. 4.89%
Gland Pharma Ltd 4.83%
DIVI'S LABORATORIES LTD. 4.53%
AUROBINDO PHARMA LTD. 3.84%
Narayana Hrudayalaya Ltd 3.34%
Zydus Lifesciences Ltd 3.31%
Medplus Health Services Ltd 3.20%
AJANTA PHARMA LTD. 3.05%
Vijaya Diagnostic Centre Ltd 3.03%
Sanofi India Ltd 2.97%
ABBOTT INDIA LTD. 2.87%
GLAXOSMITHKLINE PHARMACEUTICALS LTD. 2.79%
Alkem Laboratories Ltd 2.74%
TORRENT PHARMACEUTICALS LTD. 2.22%
FORTIS HEALTHCARE LTD. 2.19%
PFIZER LTD. 2.00%
Thyrocare Technologies Ltd 1.56%
Syngene International Ltd 1.22%
Orchid Pharma Ltd 1.05%
INDOCO REMEDIES LTD. 0.99%
Metropolis Healthcare Ltd 0.49%
Jubilant Pharmova Ltd 0.46%
HealthCare Global Enterprises Ltd 0.22%
Tarsons Products Ltd 0.16%
ASTRAZENECA PHARMA INDIA LTD. 0.11%